Nucleic Acids as Gene Anticancer Drug Delivery Therapy

個数：

電子版価格
¥34,696

電子版あり

Nucleic Acids as Gene Anticancer Drug Delivery Therapy

Madkour, Loutfy H.

ウェブストア価格 ¥44,211（本体¥40,192）
Academic Press Inc（2019/08発売）
外貨定価 US$ 200.00
ポイント 401pt

提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
【重要ご説明事項】
1. 納期遅延や、ご入手不能となる場合が若干ございます。
2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
3. 美品のご指定は承りかねます。

●3Dセキュア導入とクレジットカードによるお支払いについて

≪洋書のご注文について≫ 「海外取次在庫あり」「国内在庫僅少」および「国内仕入れ先からお取り寄せいたします」表示の商品でもクリスマス前(12/20～12/25)および年末年始までにお届けできないことがございます。あらかじめご了承ください。

【入荷遅延について】
世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。

◆画像の表紙や帯等は実物とは異なる場合があります。

◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
また、洋書販売価格は、ご注文確定時点での日本円価格となります。
ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。

製本 Paperback:紙装版/ペーパーバック版／ページ数 650 p.
言語 ENG
商品コード 9780128197776
DDC分類 615.31

Full Description

Nucleic Acids as Gene Anticancer Drug Delivery Therapy highlights the most recent developments in cancer treatment using nucleic acids, nanoparticles and polymer nanoparticles for genomic nanocarriers as drug delivery, including promising opportunities for targeted and combination therapy. The development of a wide spectrum of nanoscale technologies is beginning to change the scientific landscape in terms of disease diagnosis, treatment, and prevention. This book presents the use of nanotechnology for medical applications, focusing on its use for anticancer drug delivery. Various intelligent drug delivery systems such as inorganic nanoparticles and polymer-based drug delivery are discussed. The use of smart drug delivery systems seems to be a promising approach for developing intelligent therapeutic systems for cancer immunotherapies and is discussed in detail along with nucleic acid-targeted drug delivery combination therapy for cancer. Nucleic Acids as Gene Anticancer Drug Delivery Therapy will be a useful reference for pharmaceutical scientists, pharmacologiests, and those involved in nanotechnology and cancer research.

1. Advanced drug delivery systems: New nanomedication technologies2. Characteristics of deoxyribonucleic acid3. Characteristics of ribonucleic acid4. Clinical applications of nucleic acid (DNA) gene therapeutics delivery systems5. Therapeutic applications of siRNA gene delivery systems6. Targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy7. Classifications of DNA binding molecules - Drug interactions8. Structures of quadruplex nucleic acids and their drug complexes9. Solvent-accessible surfaces of proteins and nucleic acids10. Nucleic acid medicines as green novel anticancer drugs11. Correlation between nucleic acids and nanoparticle therapeutics for cancer treatment12. Drug delivery systems as advanced nanotechnology13. Nanoparticle and polymeric nanoparticle-based targeted drug delivery systems14. Polymer nanoparticle drug-nucleic acid combinations15. Combinational delivery therapies of nucleic acids for cancer treatment16. Multiple delivery of drug-nucleic acid combinations for cancer treatment17. FDA and the medical device clinical drug trials18. Biological barriers to cancer drug delivery, efficacy and cancer models19. Toxicological considerations of clinically applicable nanoparticles20. DNA complexes as an efficient gene anticancer drug delivery therapy21. Immunotherapy with mRNA vaccination and immunomodulation nanomedicine for cancer therapy